Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022

SELL
$28.19 - $46.6 $6.9 Million - $11.4 Million
-244,679 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$41.2 - $73.6 $2.4 Million - $4.29 Million
58,355 Added 31.32%
244,679 $11.1 Million
Q3 2021

Nov 03, 2021

SELL
$59.15 - $91.99 $3.36 Million - $5.23 Million
-56,850 Reduced 23.38%
186,324 $11.8 Million
Q2 2021

Jul 30, 2021

SELL
$63.02 - $95.11 $1.56 Million - $2.36 Million
-24,805 Reduced 9.26%
243,174 $22.3 Million
Q1 2021

Apr 30, 2021

SELL
$57.62 - $95.6 $2.68 Million - $4.44 Million
-46,460 Reduced 14.78%
267,979 $18.2 Million
Q4 2020

Jan 29, 2021

SELL
$41.43 - $77.09 $6.05 Million - $11.3 Million
-146,038 Reduced 31.71%
314,439 $22.8 Million
Q3 2020

Oct 30, 2020

SELL
$30.88 - $37.94 $183,581 - $225,553
-5,945 Reduced 1.27%
460,477 $17.5 Million
Q2 2020

Aug 03, 2020

SELL
$18.95 - $35.43 $78,263 - $146,325
-4,130 Reduced 0.88%
466,422 $16.5 Million
Q1 2020

Apr 30, 2020

BUY
$13.94 - $28.25 $588,156 - $1.19 Million
42,192 Added 9.85%
470,552 $10.3 Million
Q4 2019

Jan 31, 2020

BUY
$19.24 - $28.41 $337,662 - $498,595
17,550 Added 4.27%
428,360 $9.24 Million
Q3 2019

Nov 04, 2019

BUY
$20.03 - $40.08 $2.03 Million - $4.05 Million
101,155 Added 32.67%
410,810 $9.29 Million
Q2 2019

Jul 31, 2019

BUY
$25.78 - $39.77 $1.79 Million - $2.77 Million
69,535 Added 28.96%
309,655 $11.1 Million
Q1 2019

May 01, 2019

SELL
$22.09 - $39.21 $5,522 - $9,802
-250 Reduced 0.1%
240,120 $7.57 Million
Q4 2018

Jan 31, 2019

BUY
$19.89 - $30.02 $4.78 Million - $7.22 Million
240,370 New
240,370 $6.04 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.13B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.